Free Trial

Solana (HSDT) Competitors

Solana logo
$15.65 -0.42 (-2.61%)
As of 10:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

HSDT vs. DXR, ICCM, QTI, TELA, CTSO, MDAI, SRTS, PYPD, SURG, and TMDIF

Should you be buying Solana stock or one of its competitors? The main competitors of Solana include Daxor (DXR), IceCure Medical (ICCM), QT Imaging (QTI), TELA Bio (TELA), Cytosorbents (CTSO), Spectral AI (MDAI), Sensus Healthcare (SRTS), PolyPid (PYPD), SurgePays (SURG), and Titan Medical (TMDIF). These companies are all part of the "medical equipment" industry.

Solana vs. Its Competitors

Daxor (NASDAQ:DXR) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

In the previous week, Solana had 7 more articles in the media than Daxor. MarketBeat recorded 10 mentions for Solana and 3 mentions for Daxor. Daxor's average media sentiment score of 1.11 beat Solana's score of 0.73 indicating that Daxor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Daxor
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solana
1 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Daxor has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Solana has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.

Daxor has higher earnings, but lower revenue than Solana.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaxorN/AN/AN/AN/AN/A
Solana$520K32.50-$11.74M-$1.98 thousand-0.01

Daxor presently has a consensus price target of $25.00, indicating a potential upside of 94.10%. Given Daxor's stronger consensus rating and higher probable upside, research analysts plainly believe Daxor is more favorable than Solana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Daxor
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Solana
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Daxor has a net margin of 0.00% compared to Solana's net margin of -7,215.25%. Daxor's return on equity of 0.00% beat Solana's return on equity.

Company Net Margins Return on Equity Return on Assets
DaxorN/A N/A N/A
Solana -7,215.25%-699.93%-415.24%

1.3% of Daxor shares are owned by institutional investors. Comparatively, 18.6% of Solana shares are owned by institutional investors. 59.5% of Daxor shares are owned by insiders. Comparatively, 17.9% of Solana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Daxor beats Solana on 8 of the 12 factors compared between the two stocks.

Get Solana News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSDT vs. The Competition

MetricSolanaMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$16.90M$6.84B$6.02B$10.34B
Dividend YieldN/A1.19%5.73%4.82%
P/E Ratio-0.0126.6184.7826.75
Price / Sales32.5027.48598.92130.97
Price / CashN/A21.8525.7730.18
Price / Book0.075.1312.476.64
Net Income-$11.74M$178.09M$3.32B$276.55M
7 Day Performance-13.82%-2.56%-0.56%-0.93%
1 Month Performance107.01%6.60%8.20%6.04%
1 Year Performance-95.65%3.31%75.60%40.02%

Solana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSDT
Solana
1.1805 of 5 stars
$15.65
-2.6%
N/A-95.6%$16.90M$520K-0.0130Gap Up
DXR
Daxor
3.929 of 5 stars
$13.81
-0.6%
$25.00
+81.0%
+48.6%$67.23MN/A0.0037Gap Down
ICCM
IceCure Medical
3.2202 of 5 stars
$1.00
+3.7%
$2.39
+138.5%
+49.6%$66.23M$3.29M-6.2560High Trading Volume
QTI
QT Imaging
N/A$2.33
+0.1%
N/A+300.7%$63.26M$4.00M0.00N/APositive News
TELA
TELA Bio
2.3272 of 5 stars
$1.52
-2.9%
$4.50
+197.0%
-38.5%$61.80M$69.30M-1.35120News Coverage
CTSO
Cytosorbents
1.9828 of 5 stars
$0.94
-4.5%
$5.50
+485.1%
-17.0%$61.76M$35.60M-5.53220Positive News
MDAI
Spectral AI
2.9227 of 5 stars
$2.42
+8.5%
$3.50
+44.6%
+85.7%$59.61M$27.55M-3.5183Gap Up
High Trading Volume
SRTS
Sensus Healthcare
2.9009 of 5 stars
$3.41
-0.6%
$8.00
+134.6%
-51.5%$56.39M$37.56M-56.8340
PYPD
PolyPid
3.1087 of 5 stars
$3.54
+1.1%
$12.40
+250.3%
-3.7%$55.64MN/A-0.9280
SURG
SurgePays
3.1289 of 5 stars
$2.87
+5.9%
$9.50
+231.0%
+31.7%$55.37M$60.88M-1.1540
TMDIF
Titan Medical
N/A$0.48
-0.3%
N/A+1,153.6%$54.74M$17.63M-0.3850

Related Companies and Tools


This page (NASDAQ:HSDT) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners